Portsmouth Technologies sold 30 lakh shares of Anthem Biosciences for Rs 249.90 crore at Rs 833 each in a BSE block deal. Anthem's Q1 FY27 profit after tax dropped 11.7% to Rs 119.94 crore. https://www.theceo.in/newsletter #anthembiosciences #blockdeal #stocks

Accel & 360 ONE sold 61.98M BlueStone shares via block deals worth ₹513 Cr at ₹827.60/share. Buyers include Mirae Asset, SBI Life, Goldman Sachs & Kuwait Investment Authority.

https://www.theceo.in/newsletter #bluestone #accel #blockdeal